Sciclone Pharma (SCLN) Reports Q1 EPS of $0.19
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St set for muted open as Middle East tensions curb risk appetite
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Form SC 13G/A SCICLONE PHARMACEUTICALS Filed by: FRANKLIN RESOURCES INC
May 9, 2016 6:07 PM EDT
CUSIP NO. 80862K104 13G Page 1 of 15
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 4)*
SCICLONE PHARMACEUTICALS, INC.
... More